Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
158,586,253
-
Share change
-
+2,173,603
-
Total reported value
-
$364,735,919
-
Put/Call ratio
-
47%
-
Price per share
-
$2.30
-
Number of holders
-
128
-
Value change
-
+$1,162,078
-
Number of buys
-
63
-
Number of sells
-
47
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q4 2018
As of 31 Dec 2018,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,586,253 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., STATE STREET CORP, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Tamarack Advisers, LP, OppenheimerFunds, Inc., Vanguard Group Inc, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
128
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.